Qilian International Holding Group Limited announces name change to BGM Group Ltd.

CHENGDU, China, Oct. 29, 2024 /PRNewswire/ — Qilian International Holding Group Ltd. (“Qilian” or the “Company”) (NASDAQ: BGM) is pleased to announce that effective October 30, 2024, the Company will change its name to “BGM Group Ltd.” In connection with the name change, the trading symbol of the Company’s Class A common stock on the Nasdaq Stock Market has been changed to “BGM” effective August 11, 2024 and the CUSIP number will remain unchanged.

About Qilian International Holding Group Ltd.

BGM Group Ltd., formerly known as Qilian International Holding Group Ltd., headquartered in Chengdu, China, is an innovative company focused on the fields of biopharmaceuticals, bioextraction and medical health. Our current product range includes oxytetracycline APIs, licorice preparations and crude heparin sodium. The oxytetracycline API not only provides raw materials for pharmaceutical companies to produce antibiotics for humans, but also supports the global breeding and livestock industry to ensure the safety of poultry and seafood. The crude heparin sodium, after processing by downstream companies, is converted into refined heparin sodium and heparin sodium injection solutions, which are important anticoagulants. Licorice preparations, such as compound licorice tablets, are used as cough suppressants and supplied to pharmacies. For more information, visit the company’s website: www.bgm.ltd.

Safe Harbor Statement

Certain statements in this press release are “forward-looking statements” within the meaning of the “safe harbor” provisions of the United States Private Securities Litigation Reform Act of 1995. When used in this press release, the words “estimates,” “projected,” “expects,” “anticipates,” “predicts,” “plans,” “plans,” “believes,” “seeks,” “may,” “will,” “should,” “future,” “propose” and variations of these words or similar expressions (or the negative versions of such words or expressions) are intended to identify forward-looking statements. These forward-looking statements are not guarantees of future performance, conditions or results and involve a number of known and unknown risks, uncertainties, assumptions and other important factors, many of which are beyond the Company’s control, that could affect actual results or outcomes could cause. differ materially from those discussed in the forward-looking statements. Key factors include the ability to control growth; ability to identify and integrate other future acquisitions; ability to obtain additional financing in the future to finance capital expenditures; fluctuations in general economic and business conditions; costs or other factors that adversely affect our profitability; litigation relating to patents, intellectual property and other matters; potential changes in the legal and regulatory environment; a pandemic or epidemic. The forward-looking statements contained in this press release are also subject to other risks and uncertainties, including those more fully described in the company’s filings with the Securities and Exchange Commission, which are available for inspection at www.sec.gov . The Company undertakes no obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by applicable law. Such information applies only as of the date of this release.

For questions from investors and media, please contact:
(email protected) , (email protected) or (email protected)

SOURCE Qilian International Holding Group Co., LTD